Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

183
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
183
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

122
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
122
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

140
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
140
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

722
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
722
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

294
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
294
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

502
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
502

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-Specific Associations between Long-term Air Pollution Exposure and Coronary Atherosclerosis at Cardiac CT.

Radiology·2026
Same author

Lessons learned from piloting a heart failure-based remote management care system in a general internal medicine program: A qualitative evaluation.

Digital health·2026
Same author

Development of Virtual Mental Health Stepped Care Service for a Heart Failure Remote Management Program: Qualitative Descriptive Study.

JMIR formative research·2026
Same author

Remote monitoring of heart failure exacerbations using a smartwatch.

Nature medicine·2026
Same author

Use of Indigenous-Based Methodologies to Enhance the Understanding of Local Context in Ugandan Communities: Protocol for a Mixed Methods Study.

JMIR research protocols·2025
Same author

Comparative Effectiveness of TAVI Platforms and Surgical Aortic Valve Replacement: A Network Meta-Analysis of Randomized Controlled Trials.

Circulation. Cardiovascular interventions·2025

Related Experiment Video

Updated: Dec 6, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.1K

Evaluation of a Heart Failure Telemonitoring Program Through a Microsimulation Model: Cost-Utility Analysis.

Chris Boodoo1, Qi Zhang1, Heather J Ross2,3,4

  • 1Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

Journal of Medical Internet Research
|October 6, 2020
PubMed
Summary

The Medly telemonitoring program for heart failure (HF) is cost-effective, improving patient outcomes and quality-adjusted life years (QALYs) compared to standard care. This study supports its use for HF management.

Keywords:
cost effectivenesscost utility analysisheart failuremicrosimulationmobile phonetelemedicine

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.7K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

441

Related Experiment Videos

Last Updated: Dec 6, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.1K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.7K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

441

Area of Science:

  • Health Economics
  • Public Health
  • Cardiology

Background:

  • Heart failure (HF) presents a significant public health challenge in Canada, marked by high prevalence, morbidity, mortality, and substantial financial and social burdens.
  • Telemonitoring (TM) interventions, such as the Medly program, have demonstrated efficacy in improving outcomes for ambulatory HF patients.
  • Despite proven patient benefits, the cost-effectiveness of the Medly TM program has not been established.

Purpose of the Study:

  • To conduct a cost-utility analysis comparing the Medly program to standard care for heart failure (HF) patients in Ontario, Canada.
  • To evaluate the economic value of the Medly program from the perspective of the public healthcare payer.
  • To determine the incremental cost-effectiveness ratio (ICER) and assess the cost-effectiveness of TM in HF management.

Main Methods:

  • A microsimulation model was employed to simulate individual patient data over a 25-year horizon.
  • The model compared costs and quality-adjusted life years (QALYs) between the Medly program and standard care for ambulatory HF patients.
  • Data from the Medly Program Evaluation study and existing literature informed model parameters, including effectiveness, costs, and transition probabilities. Sensitivity analyses were performed.

Main Results:

  • The Medly program yielded higher total QALYs (5.51) at an incremental cost of Can $5011 (US $3794) per patient, resulting in an ICER of Can $8850 (US $6701)/QALY.
  • Cost-effectiveness was enhanced for patients with advanced HF and when patients utilized their own monitoring equipment.
  • Probabilistic sensitivity analysis indicated a >85% probability of cost-effectiveness at a willingness-to-pay threshold of Can $50,000 (US $37,718).

Conclusions:

  • The Medly telemonitoring program for heart failure (HF) demonstrates cost-effectiveness compared to standard care within typical willingness-to-pay thresholds.
  • The findings support the adoption of nurse-led telemonitoring models with validated algorithms for HF management.
  • This study highlights the value of economic modeling for evaluating early-stage health informatics technologies in healthcare.